Kerydin

Discussion in 'Dermatology' started by anonymous, May 15, 2018 at 7:25 PM.

Tags: Add Tags
  1. anonymous

    anonymous Guest

    A recruiter reached out to me about a position selling Kerydin. Anyone have experience with this topical? Territory is Louisiana. I’ve never sold antifungals, but the recruiter made it seem like a good gig.
     

  2. anonymous

    anonymous Guest

    I would not sell kerydin. They already did a big downsize of that sales force. It’s not covered on any formularies and has bad efficacy data.
     
  3. anonymous

    anonymous Guest

    read the news. Novartis can't wait to unload the division. You'll have a job for maybe 6 months. Maybe
     
  4. anonymous

    anonymous Guest

    No one writes this drug. Doesn’t work, isn’t covered. Only docs who write are speakers for the company and they will write maybe 1 a month out of pitty. Jublia and generics own the market.
     
  5. anonymous

    anonymous Guest

    Avoid, entire division is on auction block. Job could be gone in a matter of months.
     
  6. anonymous

    anonymous Guest

    Novartis can't wait to unload the division. You'll have a job for maybe 6 months.
     
  7. anonymous

    anonymous Guest

    They already did a big downsize of that sales force. It’s not covered on any formularies and has bad efficacy data.
     
  8. anonymous

    anonymous Guest

    Only docs who write are speakers for the company and they will write maybe 1 a month out of pitty. Jublia and generics own the market.
     
  9. anonymous

    anonymous Guest

    Everyone writes this drug. Doesn’t work, isn’t covered. Only docs who write are speakers for the company and they will write maybe 1 a month out of pitty. Jublia and generics own the market.
     
  10. anonymous

    anonymous Guest

    Jublia and generics own the market.
     
  11. anonymous

    anonymous Guest

    Contacted about opening in LA (Pasadena).Anyone have info on territory, company or product? Not new to pharma but never sold in derm.
     
  12. anonymous

    anonymous Guest

    Just had a huge layoff, it is the most expensive drug in its class- aprox $1500.00 w cure rate of about 10% in a year plus not covered by most plans and less effective than laminal for less than $10.00 w cure rate of 60%. No security here...
     
  13. anonymous

    anonymous Guest

    Miserable drug to be a rep for. It doesn’t work, is expensive and sadly can’t touch the competition. Not good place to be in derm.
     
  14. anonymous

    anonymous Guest

    Only docs who write are speakers for the company and they will write maybe 1 a month out of pitty. Jublia and generics own the market.